Back to results
US 2019/0241578 A1Published application
Novel compositions useful in treating brain-related diseases or disorders and methods using same
AssigneeDrexel University
InventorsSandhya KORTAGERE, Ole MORTENSEN, Andreia C. K. MORTENSEN, Joseph M. SALVINO
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.
Claims20
A compound of Formula (II):
- wherein:
- ring A is a monocyclic or bicyclic aryl or a monocyclic or bicyclic heteroaryl ring, and wherein the aryl or heteroaryl ring is optionally substituted with 1-4 R1 groups;
- ring B is a monocyclic or bicyclic arenediyl or a monocyclic or bicyclic heteroarenediyl ring, and wherein the arenediyl or heteroarenediyl ring is optionally substituted with 1-4 R2 groups;
- each occurrence of R1 and R2 is independently selected from the group consisting of C1-C6 alkyl, C1-C6 fluoroalkyl, C1-C6 heteroalkyl, F, Cl, Br, I, —CN, —NO2, —OR5, —SR5, —S(═O)R5, —S(═O)2R5, —(CH2)0-2NHS(═O)2R5, —(CH2)0-2C(═O)R5, —OC(═O)R5, —(CH2)0-2CO2R5, —OCO2R5, —CH(R5)2, —(CH2)0-2N(R5)2, —(CH2)0-2C(═O)N(R5)2, —OC(═O)N(R5)2, —(CH2)0-2NHC(═O)NH(R5), —(CH2)0-2NHC(═O)R5, —(CH2)0-2NHC(═O)OR5, —C(OH)(R5)2, and —C(NH2)(R5)2;
- R3 is selected from the group consisting of H, C1-C6 alkyl, —OR5, —S(═O)R5, —S(═O)2R5, —C(═O)R5, —CO2R5, —CH(R5)2, and —C(═O)N(R5)2;
- R4 is selected from the group consisting of —OR5, —SR5, —S(═O)R5, —S(═O)2R5, —NHS(═O)2R5, —C(═O)R5, —OC(═O)R5, —CO2R5, —OCO2R5, —CH(R5)2, —N(R5)2, —C(═O)N(R5)2, —OC(═O)N(R5)2, —NHC(═O)NH(R5), —NHC(═O)R5, —NHC(═O)OR5, —C(OH)(R5)2, —C(NH2)(R5)2, C1-C6 alkyl, C3-C10 cycloalkyl, (C4-C10)heterocycle, (C6-C10)aryl, and (C5-C10)heteroaryl, wherein the alkyl, heteroalkyl, cycloalkyl, heterocycle, aryl and heteroaryl groups are independently optionally substituted;
- each occurrence of R5 is independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 heteroalkyl, C3-C10 cycloalkyl, —C1-C3 alkyl-(C3-C6 cycloalkyl), (C4-C10)heterocycle, —C1-C3 alkyl-(C4-C10heterocycle), (C6-C10)aryl, —C1-C3 alkyl-(C6-C10aryl), (C5-C10)heteroaryl, and —C1-C3 alkyl-(C5-C10 heteroaryl), wherein the alkyl, heteroalkyl, cycloalkyl, heterocycle, aryl and heteroaryl groups are independently optionally substituted;
- and
- x and y are independently an integer from 0-4;
- a salt or solvate thereof, and any combinations thereof.
7 more elements
Dependencies are inferred from the claim text.